产品中心 抗体 其他一抗

所有图片(1/4)

Glucocorticoid Receptor Recombinant Rabbit mAb (S-M0030)

GRL,NR3C1

价格 600.00 供应商现货 : 3-5个工作日
货号 S0B60076
规格
数量
收藏 分享

产品介绍 评论(0)

产品规格
  • 宿主来源

    Rabbit
  • 抗原名称

    Glucocorticoid Receptor
  • 分子别名

    GRL; NR3C1
  • 细胞定位

    Cytoplasm, Nucleus
  • Accession

    P04150
  • 克隆号

    S-M0030
  • 抗体类型

    Recombinant mAb
  • 抗体同种型

    IgG
  • 反应种属 ?

    Hu, Ms, Rt, Mk
  • 阳性样本

    HepG2, HeLa, A549, HT-1080, U-87 MG, mouse liver, mouse kidney, rat liver, C6, COS-7
  • 纯化方式

    Protein A
  • 浓度

    0.25 mg/ml
  • 标记

    Unconjugated
  • 性状

    Liquid
  • 缓冲体系

    PBS, 40% Glycerol, 0.05% BSA, 0.02% sodium azide

  • 储存条件

    12 months from date of receipt / reconstitution, -20 °C as supplied

  • 应用

    WB

    IP

  • 稀释度

    应用 稀释度 推荐种属
    WB 1:500-1:2000 Hu, Ms, Rt, Mk
    IP 1:50 Hu, Ms, Rt, Mk
背景介绍
  • Glucocorticoid Receptor (GR) is a member of the nuclear receptor superfamily encoded by the NR3C1 gene, existing in several splice variants, among which GRα is the major functional isoform. In the absence of ligand, GR is primarily localized in the cytoplasm and forms a complex with molecular chaperones such as heat shock proteins to maintain its inactive conformation. Upon binding of glucocorticoids (e.g., cortisol or dexamethasone), GR undergoes a conformational change, dissociates from chaperone proteins, and rapidly translocates to the nucleus. Once in the nucleus, GR acts through two main mechanisms: directly binding to glucocorticoid response elements (GREs) in DNA to activate or repress target gene transcription (i.e., transactivation and transrepression), and modulating the expression of inflammation- and immune-related genes via protein-protein interactions with other transcription factors such as NF-κB and AP-1. This dual regulatory mechanism positions GR as a core regulator of the stress response, metabolic regulation (including gluconeogenesis and lipolysis), and anti-inflammatory actions. Dysregulation of GR signaling is closely linked to the pathogenesis of Cushing's syndrome, glucocorticoid resistance, and various autoimmune diseases, making GR an important drug target for conditions such as asthma, rheumatoid arthritis, and leukemia.

  • 免疫印迹

    • WB result of Glucocorticoid Receptor Recombinant Rabbit mAb
      Primary antibody: Glucocorticoid Receptor Recombinant Rabbit mAb at 1/500 dilution
      Lane 1: HepG2 whole cell lysate 20 µg
      Lane 2: HeLa whole cell lysate 20 µg
      Lane 3: A549 whole cell lysate 20 µg
      Lane 4: HT-1080 whole cell lysate 20 µg
      Lane 5: U-87 MG whole cell lysate 20 µg
      Secondary antibody: Goat Anti- rabbit IgG, (H+L), HRP conjugated at 1/10000 dilution
      Predicted MW: 86 kDa
      Observed MW: 95 kDa

    • WB result of Glucocorticoid Receptor Recombinant Rabbit mAb
      Primary antibody: Glucocorticoid Receptor Recombinant Rabbit mAb at 1/500 dilution
      Lane 1: mouse liver lysate 20 µg
      Lane 2: mouse kidney lysate 20 µg
      Secondary antibody: Goat Anti- rabbit IgG, (H+L), HRP conjugated at 1/10000 dilution
      Predicted MW: 86 kDa
      Observed MW: 95 kDa

    • WB result of Glucocorticoid Receptor Recombinant Rabbit mAb
      Primary antibody: Glucocorticoid Receptor Recombinant Rabbit mAb at 1/500 dilution
      Lane 1: C6 whole cell lysate 20 µg
      Lane 2: rat liver lysate 20 µg
      Secondary antibody: Goat Anti- rabbit IgG, (H+L), HRP conjugated at 1/10000 dilution
      Predicted MW: 86 kDa
      Observed MW: 95 kDa

    • WB result of Glucocorticoid Receptor Recombinant Rabbit mAb
      Primary antibody: Glucocorticoid Receptor Recombinant Rabbit mAb at 1/500 dilution
      Lane 1: COS-7 whole cell lysate 20 µg
      Secondary antibody: Goat Anti- rabbit IgG, (H+L), HRP conjugated at 1/10000 dilution
      Predicted MW: 86 kDa
      Observed MW: 95 kDa

评论(0)